External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Macula Society 2024
Roche and Genentech at

Macula Society 2024

February 07 - February 10
California, USA
maculasociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
05:22 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Efficacy, Safety, and Durability of Faricimab▼ in Macular Edema Due to Retinal Vein Occlusion: 72-week Results From the Phase 3 BALATON and COMINO Trials
Kuriyan A, Abreu F, Arrisi P, Kotecha A, Liu Y, Retiere A, Willis J, Paris L
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:14 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Greater Volume Reduction of Hyperreflective Foci in DME With Faricimab▼ vs Aflibercept in Phase 3 YOSEMITE/RHINE
Chakravarthy U, Singh RP, Maunz A, Von Schulthess E, Patel K, Bachmeier I, Jones I, Cohen Y, Gibson K, Willis J, Glittenberg C, Fauser S
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:50 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Greater Reduction in Pigment Epithelial Detachment Size With Faricimab▼ vs Aflibercept During Head-to-Head Dosing in nAMD
Avery R, Lai T, Souverain A, Yang M, Willis J, Kotecha A, Patel S, Margaron P, Lim J, Khanani A
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:41 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Efficacy and Safety of Faricimab▼ in ALTIMETER: A Trial Exploring Biomarkers of Ang-2 Inhibition in Patients With DME
Vujosevic S, Amador M, Dieckmann A, Gibson K, Glittenberg C, Kotak A, Mar F, Souverain A, Titz B, Fawzi A
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:48 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema (DME): A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)
Leng T, Holekamp N, Mar F, Gibson K, Paulo T, Buehrer C, Tabano D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:55 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Impact of Faricimab▼ vs Aflibercept on Epiretinal Membrane Formation Over 2 Years in Eyes with DME in the YOSEMITE/RHINE Phase 3 Trials
Jaffe G, Ogura Y, Deak G, Gibson K, Schmidt-Erfurth U, Wang T, Westenskow P, Willis J
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:07 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Port Delivery System with Ranibizumab (PDS) Stabilizes Retinal Nonperfusion in Patients with Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR): Results from Pagoda and Pavilion Phase 3 Trials
Gill M, Howard D, Menezes A, Rahman S, Latkany P
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:14 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
The Return of PDS: Port Delivery System with Ranibizumab Is Back To Enable Continuous Delivery Of Anti-VEGF Therapy For Patients with nAMD, DME, and DR
de Juan E, Pieramici D, Campochiaro P, Chang M, Holekamp N, Gune S, Quezada Ruiz C, Wise G, Ranade S, Horvath J, Regillo C
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:21 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Extended Dosing of Faricimab▼ in the Phase 3 YOSEMITE/RHINE and TENAYA/LUCERNE Trials
Lim J, Singer M, Amador M, Hill L, Idowu O, Patel S, Yang M, Gibson K, Margaron P
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:35 PM
Duration 7mins La Quinta Resort & Club, Palm Springs, California
Real-World Clinical and Anatomical Outcomes in Patients With Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treated With Faricimab▼ in the United States: The FARETINA Study
Dedania V, Tabano D, Borkar D, Garmo V, Leng T, Shaia J, Kuo B, Myers R, LaPrise A, Ali F, Singh R
Ophthalmology | Diabetic Macular Edema - Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.